+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Neurointerventional Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • ID: 4997422
  • Report
  • January 2022
  • Region: Global
  • 120 Pages
  • Mordor Intelligence


  • Abbott Laboratories
  • Medtronic plc
  • Penumbra, Inc.
  • Stryker
  • Terumo Corporation

The neurointerventional devices are used by medical professionals specialized in the domain of central nervous system (CNS). It is usually practised by neuroradiologists, neurosurgeons and neurologists exploring the endovascular approach to treat the vascular diseases of the CNS. A wide range of vascular diseases burden associated with the CNS primarily drives the usage of devices. As per the American Association of Neurological Surgeons, Stroke is the third leading cause of death in the United States. About 700,000 are affected each year of which, 200,000 are the recurrent attacks cases. The consistent high volume of patients with vascular diseases approaching the healthcare facilities, increases the demand of the neurointerventional devices in a region. The direct and indirect high cost of the devices and procedure as well as stringent regulations are some of primary limitations to the growth of the studied market.

Key Market Trends

Treatment of Ischemic Stroke is Expected to Hold Major Share of the Market Over the Forecast Period

  • Ischemic stroke refers to the blockade of an artery in the brain. It accounts to about 87% of all the strokes, therefore, is of primary concerns to the medical professional associated with the treatment of CNS diseases.
  • The revascularization devices are a common solution of the treatment of such injuries. The Solitaire™ X Revascularization Device by the Medtronic PLC, is indicated to restore the blood flow from a large intracranial vessel in patients experiencing ischemic stroke.
  • With wide range of applications linked to the arterial based diseases correction, there is significant usage of the neurointerventional devices. Thus, across all kind of diseases linked to CNS, the demand for neurinterventional devices is expected to steadily grow over the forecast period.

North America is Expected to Hold a Significant Share in the Market with Similar Trend in the Forecast Period

North America with its advanced healthcare infrastructure across majority of places, and presence of many medical devices companies well-connected with the hospitals primarily boost the growth of this market. In the United States, it is estimated that atleast one stroke within every 40 seconds occurs and every four minutes, someone dies of a stroke. Approximately 87% of all strokes are ischemic strokes, in which blood flow to the brain gets blocked. Similarly, as per stated by the Brain Aneurysm Foundation, cerebral aneurysms affect an estimated 6 million Americans and are accountable for nearly half a million deaths worldwide each year, with half the victims age 50 and younger. The presence of several foundations which acts support systems for many healthcare providers associated with the treatment of CNS vascular diseases also fuels the use of neurointerventional devices market.

Competitive Landscape

The companies have identified consistent growth opportunities in the treatment of endovascular based diseases via neurostimulation devices. Some of the major companies in this segment include Abbott Laboratories, Johnson & Johnson (DePuy Synthes), Medtronic plc, Stryker, Penumbra, Inc., and others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

This product will be delivered within 2 business days.
Note: Product cover images may vary from those shown


  • Abbott Laboratories
  • Medtronic plc
  • Penumbra, Inc.
  • Stryker
  • Terumo Corporation

1.1 Study Assumptions
1.2 Scope of the Study
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Target Patient Population
4.2.2 Ongoing Product Development and Commercialization
4.2.3 Rising Research Activities in the Field of Neurovascular Therapies
4.3 Market Restraints
4.3.1 Stringent Regulations
4.3.2 Dearth of Skilled Neurosurgeons
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5.1 By Product
5.1.1 Aneurysm Coiling & Embolization Devices
5.1.2 Cerebral Balloon Angioplasty and Stenting Systems
5.1.3 Neurothrombectomy Devices
5.1.4 Other Devices
5.2 By Application
5.2.1 Ischemic Stroke
5.2.2 Cerebral Aneurysms
5.2.3 Arteriovenous Malformation and Fistulas
5.2.4 Other Diseases
5.3 Geography
5.3.1 North America United States Canada Mexico
5.3.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
5.3.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.3.4 Middle-East and Africa GCC South Africa Rest of Middle-East and Africa
5.3.5 South America Brazil Argentina Rest of South America
6.1 Company Profiles
6.1.1 Abbott Laboratories
6.1.2 Johnson & Johnson (DePuy Synthes)
6.1.3 Medtronic plc
6.1.4 MicroPort Scientific Corporation
6.1.5 Penumbra, Inc.
6.1.6 Stryker
6.1.7 Terumo Corporation
6.1.8 W. L. Gore & Associates, Inc.
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Abbott Laboratories
  • Johnson & Johnson (DePuy Synthes)
  • Medtronic plc
  • MicroPort Scientific Corporation
  • Penumbra, Inc.
  • Stryker
  • Terumo Corporation
  • W. L. Gore & Associates, Inc.
Note: Product cover images may vary from those shown